These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-000565-34 A PHASE II, MULTI-CENTRE, OPEN LABEL STUDY OF MELPHALAN, PREDNISONE, THALIDOMIDE AND BORTEZOMIB IN ADVANCED AND REFRACTORY MULTIPLE MYELOMA PATIENTS. not-yet-due
Ongoing 2004-000669-36 A MULTICENTER, OPEN LABEL STUDY OF ORAL MELPHALAN, PREDNISONE AND CC-5013 (REVLIMID) (MPR) AS INDUCTION THERAPY IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. not-yet-due
Ongoing 2004-001588-22 PHARMACOKINETIC/PHARMACODINAMIC STUDY OF TRANSDERMAL BUPRENORPHINE FOR TREATMENT OF CHRONIC, MEDIUM-SEVERE, NON-ONCOLOGIC PAIN. not-yet-due
Ongoing 2004-002125-42 EFFECT OF PROLONGED TREATMENT WITH TH9507 ON IGF-I LEVELS IN ADOLESCENTS WITH ISOLATED GH DEFICIENCY DUE TO HYPOTHALAMIC PATHOGENESIS not-yet-due
Ongoing 2004-003495-11 PHASE III STUDY OF CHEMOHORMONAL THERAPY WITH TO DIFFERENT MODALITIES CONCOMITANT OR ALTERNATE VERSUS HORMONAL THERAPY ALONE IN ADVANCED PROSTATE CANCER PATIENTS. not-yet-due
Ongoing 2004-004124-12 LACTOBACILLUS REUTERI REUTERIN AS A THERAPEUTIC AGENT IN INFANTILE COLIC A PROSPECTIVE STUDY. not-yet-due
Completed, but no date 2004-004203-38 ADMINISTRATION S EFFECTS OF L-ARGININE AND N-ACETYLCYSTEINE ON NITRIC OXIDE S PRODUCTION AND ON BLOOD PRESSURE IN DIABETIC AND HYPERTENSIVE PATIENTS. bad-data
Ongoing 2004-005049-36 CAMPATH-1H MONOCLONAL ANTIBODY AS MANTEINANCE THERAPY AFTER FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINATION REGIMEN AS 2ND LINE TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA not-yet-due
Ongoing 2004-005108-33 RANDOMISED CONTROLLED STUDY ON EARLY RENSPONSE TO COMBINED ANTIVIRAL THERAPY IN CHRONIC H EPATITIS C PATIENTS GENOTIPE 2 AND 3 WITH HCV-RNA NEGATIVE WEEK 4 not-yet-due
Ongoing 2004-005112-83 RANDOMISED CONTROLLED STUDY ON EARLY RESPONSE TO COMBINED ANTIVIRAL THERAPY IN CHRONIC EPATITES C PATIENT GENOTIPE 1 AND 4 WITH HCV RNA NEGATIVE WEEK 6 not-yet-due
Ongoing 2005-000431-22 VALUTATION OF PLACEBO EFFECT AFTER CONDITIONING WITH APOMORPHINE AND WITHOUT PHARMACOLOGICAL CONDITIONING ON THE RIGIDITY AND ELECTRICAL ACTIVITY OF NEURONS OF SUBTHALAMIC NUCLEUS IN PARKINSON PATIENT... not-yet-due
Ongoing 2005-001606-66 OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS not-yet-due
Completed, but no date Terminated 2005-002072-15 EFFECTS OF TREATMENT WITH L-ARGININE ASSOCIATED TO N-ACETILCYSTEINE IN PATIENTS WITH CORONARY ISCHEMIC CARDIOPATHY EVALUATED WITH MYOCARDIAL SPECT (TC99) WITH EXERCISE bad-data
Completed, but no date 2005-002091-15 POLICYSTIC OVARIAN SYNDROME AND NITRIC OXIDE. EFFECTS OF TREATMENT WITH N-ACETYLCYSTEINE AND ARGININE bad-data
Ongoing 2005-002368-27 EFFECT OF AN ANTI-OXIDANT TREATMENT ON RESISTIN SERUM LEVELS. A RANDOMISED STUDY not-yet-due
Ongoing 2005-003248-75 PILOT STUDY ON SAFETY AND TOLERABILITY OF REPEATED MOBILIZATION PROCEDURES OF OSTEO-MEDULLARY DERIVED CELLS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS not-yet-due
Ongoing 2005-003293-25 A PHASE II, MULTI-CENTER, OPEN LABEL STUDY OF MELPHALAN, PREDNISONE, THALIDOMIDE AND DEFIBROTIDE IN ADVANCED AND REFRACTORY MULTIPLE MYELOMA PATIENTS not-yet-due
Ongoing 2005-003853-29 A randomized, controlled, multicenter clinical trial comparing the efficacy of Peginterferon alfa-2a and ribavirin and metformin versus Peginterferon alfa-2a and ribavirin for the treatment of naïve p... not-yet-due
Ongoing 2005-004590-24 PHASE II PILOT PROTOCOL OF BONEMARROW STAM CELLS MOBILIZATION BY CYTOCHINE STIMULATION IN PATIENTS WITH COMPLEX ANAL FISTULAS AND/OR RECURRENCES AND/OR ANAL-PERIANAL LOCALIZATIONS OF IBD not-yet-due
Ongoing 2005-004940-29 VOLUNTARY TERMINATION OF PREGNANCY WITH MIFEPRISTONE RU486 AND MISOPROSTOL not-yet-due
Ongoing 2005-005152-40 MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, TRIAL ON ALPHA-LIPOIC ACID FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS ALALS not-yet-due
Ongoing 2005-005661-11 PHASE II STUDY OF NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER not-yet-due
Ongoing 2005-005725-64 PHASE II CLINICAL AND PHARMACOKINETIC STUDY OF PEGYLATED LIPOSOMAL DOXORUBICIN AND GEMCITABINE IN ADVANCED OVARIAN CARCINOMA not-yet-due
Completed, but no date 2006-001796-37 Effect of alendronate on spontaneous osteoclastogenesis in postmenopausal osteoporosis bad-data
Ongoing 2006-002958-29 STUDY OF CIRCULATING OSTEOBLAST-LINEAGE CELLS IN RELATION WITH TERIPARATIDE THERAPY. not-yet-due
Ongoing 2006-002978-21 SPERIMENTAL STUDY ON THE CLINICAL EFFECT OF POLI UNSATURATED FATTY ACIDS w-3 AND ON THEIR ANTIFLAMMATORY AND ANTI OXIDANT ACTION IN LUNG CANCER PATIENTS DURING CHEMIOTHERAPY not-yet-due
Ongoing 2006-002992-42 A phase II study to evaluate the efficacy of bevacizumab in combination with capecitabine and concomitant radiotherapy in patients affected by non-resectable locally advanced pancreatic cancer. not-yet-due
Completed, but no date 2006-005090-21 Noradrenalin vs terlipressin in patients with hepatorenal syndrome bad-data
Ongoing 2006-006236-22 Use of Metformin to reduce serum level of Testosterone and improve the metabolic picture in women treated for breast cancer not-yet-due
Ongoing 2007-000386-38 PRIMARY CHEMOTHERAPY WITH AN EXTENDED SCHEDULE OF TEMOZOLOMIDE (1 WWEK ON / 1 WEEK OFF) FOR LOW GRADE OLIGODENDROGLIAL TUMORS AT RELAPSE OR PROGRESSION AFTER SURGERY: PHASE II TRIAL not-yet-due
Ongoing 2007-001705-21 Phase II study to evaluate hepatic function and clinical aspects in patients with severe hepatic cirrhosis treated with multiple cycle of stem cells mobilisation by G-CSF administration. not-yet-due
Ongoing 2007-001733-34 Albumin 4 gr/L vs 8 gr/L in the Prevention of Post-Paracentesis Circulatory Dysfunction in Cirrhotic Patients With Ascites not-yet-due
Ongoing 2007-001942-42 Pharmacokinetical-clinical study of intravescical gemcitabine in patients with marker lesion of superficial transitional cell carcinoma of the bladder not-yet-due
Ongoing 2007-002058-41 EFFICACY EVALUATION OF TADALAFIL 20 MG ON DEMAND VS TADALAFIL 5 MG DAILY AS TREATMENT MODALITY FOR ERECTILE DYSFUNCTION FOLLOWING RADICAL RADIOTHERAPY IN PROSTATIC CANCER not-yet-due
Ongoing 2007-002109-32 USE OF FENOLDOPAM TO IMPROVE GLOMERULAR FILTRATION RATE IN EARLY RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION not-yet-due
Ongoing 2007-002624-15 Fertomcidina モUヤ vs chlorhexidine 0.2% in recurrent aphthous stomatitis: randomized comparative double-blind study. not-yet-due
Ongoing 2007-003075-39 PROTOCOL OF TREATMENT WITH DOCETAXEL-GEMCITABINE IN OLD OR UNFIT PATIENTS WITH NSCLC STAGE IIIA, IIIB E IV. PHASE II TRIAL not-yet-due
Ongoing 2007-003098-21 INTEGRATED PROTOCOL OF CHEMO-RADIOTHERAPY IN THE TREATMENT OF THE OLD PATIENTS WITH NSCLC STAGE III. PHASE II TRIAL not-yet-due
Completed, but no date 2007-004099-38 INDUCTION CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY CONCOMITANT TO CETUXIMAB IN HEAD AND NECK SQUAMOUS CELL CARCINOMA: PHASE II STUDY bad-data
Ongoing 2007-005090-65 New therapeutic approaches in the treatment of anaplastic thyroid cancer: a phase II trial of valproic acid and paclitaxel in solid tumours not-yet-due
Ongoing 2008-000934-35 Activities of prolonged administration of vinorelbine or capecitabine oral to increase time to progression in patients with stable disease after the first line treatment with vinorelbine + xeloda. Ran... not-yet-due
Ongoing 2008-000936-42 DNA repair gene expression levels in NSCLC patients treated with platinum based chemotherapy: an open label randomized phase II study not-yet-due
Ongoing 2008-001094-15 SINGLE-BLIND, RANDOMIZED, PARALLEL GROUP, DOSE-FINDING TRIAL ON LITHIUM FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) not-yet-due
Ongoing 2008-002085-63 TREATMENT OF CHRONIC PAIN BY NEUROMODULATION WITH LOCAL ANESTHETIC (NEURALTHERAPY) IN OPERATED AND / OR IRRADIATED PATIENTS FOR HEAD AND NECK, BREST AND, INTRATHROCIC NEOPLASM not-yet-due
Ongoing 2008-003630-17 Evaluation of the effacay of the intravesical thermochemotherapy with mitomycin C in intermediate risk superficial bladder tumors recurrent after BCG. not-yet-due
Ongoing 2008-004220-23 EFFECT OF SUPPLEMENTATION WITH CHOLECALCIFEROL ON GLUCOSE AND LIPID METABOLISM, BLOOD PRESSURE, BONE MASS, QUALITY OF LIFE, CARDIOVASCULAR MORBIDITY AND MORTALITY IN PATIENTS WITH ISCHAEMIC HEART DISE... not-yet-due
Ongoing 2008-004762-83 Evaluation of the diagnostic efficacy of the CT cholangiography performed by administering an intra-venous contrast medium with biliary excretion (Biliscopin) in patients with malignancies of the bile... not-yet-due
Completed, but no date Terminated 2008-004904-29 PREDICTIVE MARKERS OF THE EFFICACY IN METASTATIC COLORECTAL TUMOR TREATED WITH CETUXIMAB - PHASE 2 STUDY bad-data
Ongoing 2008-005221-11 New therapeutic approaches for anaplastic thyroid cancer: assessment of the benefit-risk profile of the combination valproic acid-paclitaxel. not-yet-due
Ongoing 2008-007404-28 Role of Estrogens in osteoclastogenesis and immunomodulation of T cells. not-yet-due
Ongoing 2008-008918-39 BRAIN DERIVED NEUROTROPHIC FACTOR AND MAJOR DEPRESSIVE DISORDER TREATMENT: CLINICAL PSYCHOLOGICAL AND PSYCHOPHARMACOTHERAPIC EVALUATIONS not-yet-due
Ongoing 2009-010418-31 Effects of the prolonged administration of N-acetylcysteine on tissutal oxigenation and healing of foot ulcers in diabetic patients. not-yet-due
Ongoing 2009-011253-40 Paroxetine or Quetiapine in Addition to Mood Stabilizers in Bipolar Depression not-yet-due
Ongoing 2009-011497-15 PILOT CLINICAL TRIAL WITH MIRCERA (methoxy polyethylene glycol-epoetin beta) IN DIALYSIS UNIT OF A.O. SAN GIOVANNI BATTISTA DI TORINO not-yet-due
Ongoing 2009-011531-13 Relative adrenal insufficiency in cirrhosis: relevance in patients with ascites and treatment with hydrocortisone in refractory ascites not-yet-due
Ongoing 2009-012397-12 Energy metabolism and the skeleton: reciprocal interplay. not-yet-due
Ongoing 2009-014534-15 EFFECT OF ACUTE ADMINISTRATION OF N-ACETYLCYSTEINE ON BLOOD PRESSURE OF PULMONARY ARTERIAL IN PRIMARY PULMONARY HYPERTENSION. not-yet-due
Ongoing 2009-014548-13 Evaluation of chemopreventive effect of a galenic preparation, comparable to a food integrator, composed by seleniomethionine, lycopene and polyphenols (green tea epigallocatechingallate and catechins... not-yet-due
Ongoing 2009-018209-32 EFFECTS OF DHEA TREATMENT ON ANTHROPOMETRIC AND METABOLIC PARAMETERS, AND ON QUALITY OF LIFE (QOL) IN PATIENTS WITH ADDISON S DISEASE UNDER GLUCORTICOID-MINERALCORTICOID SUBSTITUTIVE TREATMENT not-yet-due
Ongoing 2011-004893-28 PHASE II STUDY OF CLOFARABINE IN COMBINATION WITH CYTARABINE AND LIPOSOMAL DOXORUBICIN IN CHILDREN WITH EITHER LYMPHOBLASTIC OR MYELOID RELAPSE OR REFRACTORY ACUTE LEUKEMIA AND IN CHILDREN WITH SECOND... not-yet-due
Exempt 2012-002120-33 Human Liver Stem Cells (HLSCs) in patients suffering from liver-based inborn metabolic diseases causing life-threatening neonatal onset of hyperammonemic encephalopathy not-yet-due
Ongoing 2014-002228-28 A double blind, placebo controlled, parallel groups, multicenter study on filgrastim in amyotrophic lateral sclerosis not-yet-due